|
male gamete generation
|
GO:0048232 |
285 |
0.119
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.118
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.118
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.115
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.112
|
|
|
cation transport
|
GO:0006812 |
399 |
0.092
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.092
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.083
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.082
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.077
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.075
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.073
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.068
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.067
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.065
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.064
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.064
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.060
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.059
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.058
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.055
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.055
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.054
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.051
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.050
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.048
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.047
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.047
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.047
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.046
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.046
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.046
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.045
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.043
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.043
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.043
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.043
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.040
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.040
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.040
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.039
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.039
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.039
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.039
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.039
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.039
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.038
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.038
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.038
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.038
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.038
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.037
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.036
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.035
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.034
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.034
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.034
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.034
|
|
|
action potential
|
GO:0001508 |
78 |
0.034
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.034
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.033
|
|
|
kidney development
|
GO:0001822 |
213 |
0.033
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.033
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.033
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.033
|
|
|
renal system development
|
GO:0072001 |
225 |
0.033
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.032
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.031
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.031
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.031
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.031
|
|
|
organ growth
|
GO:0035265 |
117 |
0.031
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.030
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.029
|
|
|
histone modification
|
GO:0016570 |
159 |
0.029
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.029
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.029
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.029
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.028
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.028
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.027
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.027
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.026
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.026
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.026
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.026
|
|
|
midgut development
|
GO:0007494 |
4 |
0.026
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.026
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.025
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.025
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.025
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.025
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.025
|
|
|
proteoglycan biosynthetic process
|
GO:0030166 |
20 |
0.025
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.024
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.024
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.024
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.024
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.024
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.024
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.023
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.023
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.023
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.023
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.022
|
|
|
gland development
|
GO:0048732 |
330 |
0.022
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.022
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.022
|
|
|
fertilization
|
GO:0009566 |
127 |
0.022
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.022
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.022
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.022
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.021
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.021
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.021
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.021
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.021
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.020
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.020
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.020
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.020
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.020
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.020
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.020
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.020
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.020
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.019
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.019
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.019
|
|
|
skin development
|
GO:0043588 |
220 |
0.019
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.019
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.019
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.019
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.019
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.019
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.019
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.019
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.019
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.019
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.019
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.018
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.018
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.018
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.018
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.018
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.018
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.018
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.018
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.018
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.018
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.018
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.018
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.018
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.018
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.018
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.018
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.018
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.018
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.018
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.018
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.017
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.017
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.017
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.017
|
|
|
sulfur compound biosynthetic process
|
GO:0044272 |
37 |
0.017
|
|
|
palate development
|
GO:0060021 |
76 |
0.017
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.017
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.017
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.017
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.017
|
|
|
learning
|
GO:0007612 |
98 |
0.017
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.017
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.017
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.016
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.016
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.016
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.016
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.016
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.016
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.016
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.016
|
|
|
associative learning
|
GO:0008306 |
61 |
0.016
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.016
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.016
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.016
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.016
|
|
|
amide transport
|
GO:0042886 |
138 |
0.016
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.016
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.016
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.016
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.016
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.016
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.016
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.016
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.016
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.016
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.015
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.015
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.015
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.015
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.015
|
|
|
protein processing
|
GO:0016485 |
163 |
0.015
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.015
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.015
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.015
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.015
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.015
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.015
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.015
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.015
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.015
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.015
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.015
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.015
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.015
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.014
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.014
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.014
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.014
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.014
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.014
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.014
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.014
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.014
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.014
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.014
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.014
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.014
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.014
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.014
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.014
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.014
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.014
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.014
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.014
|
|
|
visual perception
|
GO:0007601 |
52 |
0.014
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.014
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.014
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.013
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.013
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.013
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.013
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.013
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.013
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.013
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.013
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.013
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.013
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.013
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.013
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.013
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.013
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.013
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.013
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.013
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.013
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.013
|
|
|
type b pancreatic cell differentiation
|
GO:0003309 |
13 |
0.013
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.013
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.013
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.013
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.013
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.013
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.013
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.013
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.013
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.013
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.013
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.013
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.013
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.013
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.012
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.012
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.012
|
|
|
positive regulation of skeletal muscle cell differentiation
|
GO:2001016 |
4 |
0.012
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.012
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.012
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.012
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.012
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.012
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.012
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.012
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.012
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.012
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.012
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.012
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.012
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.012
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.012
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.012
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.012
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.012
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.012
|
|
|
lung development
|
GO:0030324 |
164 |
0.012
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.012
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.012
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.012
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.012
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.012
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.012
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.012
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.012
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.012
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.012
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.012
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.012
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.011
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.011
|
|
|
response to drug
|
GO:0042493 |
75 |
0.011
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.011
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.011
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.011
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.011
|
|
|
habituation
|
GO:0046959 |
3 |
0.011
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.011
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.011
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.011
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.011
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.011
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.011
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.011
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.011
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.011
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.011
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.011
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.011
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.011
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.011
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.011
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.011
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.011
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.011
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.011
|
|
|
placenta development
|
GO:0001890 |
140 |
0.011
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.011
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.011
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.011
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.011
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.011
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.011
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.011
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.011
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.011
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.011
|
|
|
coagulation
|
GO:0050817 |
78 |
0.011
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.011
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.011
|
|
|
regionalization
|
GO:0003002 |
337 |
0.011
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.011
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.011
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.011
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.011
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.011
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.011
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.011
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.011
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.011
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.010
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.010
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.010
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.010
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.010
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.010
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.010
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.010
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.010
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.010
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.010
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.010
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.010
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.010
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.010
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.010
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.010
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.010
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.010
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.010
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.010
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.010
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.010
|
|